Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mohammed Zammo"'
Publikováno v:
International Medical Case Reports Journal. 13:331-334
Secukinumab, "an IL-17 antagonist", is one of the biological agents used to treat active ankylosing spondylitis (AS). Although it has been proven that certain agents are linked with a paradoxical increase in uveitis, there are limited data on whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5aecb2d155198e074e20ec2bd819d7
https://doi.org/10.2147/imcrj.s265812
https://doi.org/10.2147/imcrj.s265812
Autor:
Sara Hesham Taha, Samar Assem Badreddine, Nehal Ahmed, Hanan Faruqui, Yasser Aldabbagh, Abdulaziz Abdullah Al Nahdi, Mohammed Zammo, Nezar Bahabri, Reem Alquraa, Ayman H. Amer Eissa, Ahmad Alzahrani, Abdullah Sameer Mansouri, Abdullah Abdelfattah Elhosiny, Mohanna Walid Alhomsy
Publikováno v:
International Journal of Infectious Diseases and Therapy. 5:118
Background: Since the first case of SARS-CoV 2 has been reported from Wuhan China back in December 2019, the virus has spread all over the world and has so far infected more than 35 million humans and led to more than one million deaths woldwide. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99a32e54ff59e634113080b4a41c64fa
https://doi.org/10.11648/j.ijidt.20200504.13
https://doi.org/10.11648/j.ijidt.20200504.13